Research study: understanding bone health in youth with obesity

UVA Tracking #
302394
Contact
Andrea Marrs
Contact Phone
434.982.0871
Official Trial Title
Bone metabolism in adolescents undergoing GLP-1 receptor agonist therapy
Study Description

The Department of Pediatrics seeks young people to join a research study. If you are 12-21 years old and have obesity, you may be eligible to join.

We want to find out whether the weight loss drug semaglutide affects bone health in young people. To do this, we want to compare bone health in people taking semaglutide with people who are being treated with diet, exercise, and lifestyle changes.

You will have 6 visits over 26 months that include:
- DXA and HRpQCT scans to assess bone health.
- Physical examinations and questionnaires.
- Hormone, nutrition, exercise, and appetite evaluation.

If you are taking semaglutide, you mut have a prescription from your regular doctor. The study doctors are not able to prescribe semaglutide for the study. Your semaglutide must be paid for by insurance. There are no other costs to be part of the study.

If you are interested in this study, please contact Andrea Marrs or Dr. Christine Burt Solorzano at misralab@uvahealth.org.

Compensation

Participants can receive up to $950 for finishing all study visits. Parking and travel costs are covered for up to $25 for each study visit.